| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/01/2013 | CN103073545A Synthetic method of N-(2-phenylol)-beta-carboline and N-(5-chlorine-2-phenylol)-beta-carboline |
| 05/01/2013 | CN103073544A Method for separating swainsonine by using counter-current chromatography |
| 05/01/2013 | CN102260257B Pyrazolo[3,4-b]pyridine derivatives and application thereof in white organic light-emitting devices |
| 05/01/2013 | CN102015711B Spiro-indole derivatives for the treatment of parasitic diseases |
| 05/01/2013 | CN102007637B Novel photosensitizer and photovoltaic element |
| 05/01/2013 | CN101941972B Preparation method of lanthanide sandwich-type phthalocyanine complex and application of lanthanide sandwich-type phthalocyanine complex in Li/SOC12 cell |
| 05/01/2013 | CN101679270B Dihydroquinone and dihydronaphthridine inhibitors of JNK |
| 05/01/2013 | CN101479255B C-MET protein kinase inhibitors for the treatment of proliferative disorders |
| 05/01/2013 | CN101323609B Method for synthesizing high antipode content benzimidazole derivative by unsymmetrical oxidizing thioether into sulphoxide |
| 04/30/2013 | US8431703 Pyrrolopyridine compounds and their use in treating disease |
| 04/30/2013 | US8431702 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds |
| 04/30/2013 | US8431595 Furanopyridine cannabinoid compounds and related methods of use |
| 04/30/2013 | US8431592 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase inhibitors |
| 04/30/2013 | US8431574 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/30/2013 | US8431564 Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
| 04/30/2013 | CA2602553C 2,4,8-trisubstituted 8h-pyrido[2,3-d]pyrimidin-7-one derivatives, compositions thereof, and uses thereof |
| 04/25/2013 | WO2013059559A2 Compounds and methods for enhancing innate immune responses |
| 04/25/2013 | WO2013059485A1 Pyridopyrimidinone inhibitors of kinases |
| 04/25/2013 | WO2013058343A1 Organic electroluminescence element and material for organic electroluminescence element |
| 04/25/2013 | WO2013058258A1 Bicyclic heterocyclic compound |
| 04/25/2013 | WO2013057251A2 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | WO2013057013A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/25/2013 | WO2013005168A3 Cannabinoid receptor modulators |
| 04/25/2013 | US20130102782 Processes and intermediates for producing azaindoles |
| 04/25/2013 | US20130102776 Anticancer agent |
| 04/25/2013 | US20130102629 Analogues for the treatment or prevention of flavivirus infections |
| 04/25/2013 | US20130102628 Crystal of fused pyridine compound salt |
| 04/25/2013 | US20130102615 Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors |
| 04/25/2013 | US20130102611 Ip receptor agonist heterocyclic compounds |
| 04/25/2013 | US20130102609 Biaryl oxyacetic acid compounds |
| 04/25/2013 | US20130102603 2,4-diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| 04/25/2013 | US20130102597 Compounds and methods for treating inflammatory and fibrotic disorders |
| 04/25/2013 | US20130102592 Oxazole tyrosine kinase inhibitors |
| 04/25/2013 | US20130102590 Pyridopyrimidinone inhibitors of kinases |
| 04/25/2013 | US20130102587 New Enzyme Inhibitor Compounds |
| 04/25/2013 | US20130102586 Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors |
| 04/25/2013 | US20130102583 Cephem compound having catechol group |
| 04/25/2013 | US20130102559 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders |
| 04/25/2013 | US20130101630 Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity |
| 04/25/2013 | US20130099206 Heterocyclic compound, organic light-emitting diode including the heterocyclic compound, and flat display device including the organic light-emitting diode |
| 04/25/2013 | US20130098770 Plating bath and method |
| 04/25/2013 | CA2852750A1 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | CA2852723A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/25/2013 | CA2851801A1 Compounds and methods for enhancing innate immune responses |
| 04/25/2013 | CA2851640A1 Pyridopyrimidinone inhibitors of kinases |
| 04/25/2013 | CA2851589A1 Bicyclic heterocyclic compound |
| 04/24/2013 | EP2583326A1 Use of substituted perylenes in organic solar cells |
| 04/24/2013 | EP2582715A2 Growth hormone secretatogue receptor antagonists and uses thereof |
| 04/24/2013 | EP2582701A1 D2 antagonists, methods of synthesis and methods of use |
| 04/24/2013 | EP2582700A2 Respiratory formulations and compounds for use therein |
| 04/24/2013 | EP2582699A1 Substituted triazolopyridines |
| 04/24/2013 | EP2582692A1 Cyclohexyl-azetidinyl antagonists of ccr2 |
| 04/24/2013 | EP2582676A1 Tetrahydroquinoline amide m1 receptor positive allosteric modulators |
| 04/24/2013 | EP2582666A2 Aryl substituted indoles and their use as blockers of sodium channels |
| 04/24/2013 | EP2582241A1 Heterocyclic fused phenanthrolinone m1 receptor positive allosteric modulators |
| 04/24/2013 | EP2240454B1 Mesoionic pesticides |
| 04/24/2013 | CN1653050B Opioid and opioid-like compounds and uses thereof |
| 04/24/2013 | CN103068826A New azacyclic compounds |
| 04/24/2013 | CN103068825A Spiroheterocyclical substituted tetramic acid derivatives |
| 04/24/2013 | CN103068824A Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases |
| 04/24/2013 | CN103068803A Imidazo[4,5-c]quinolines as DNA-PK inhibitors |
| 04/24/2013 | CN103068391A Morpholino pyrimidines and their use in therapy |
| 04/24/2013 | CN103059042A Thiophene derivative and application thereof to medicine |
| 04/24/2013 | CN103059021A Preparation process of high-purity sophoramine |
| 04/24/2013 | CN103059020A Rutaecarpin derivative, and preparation method as well as application thereof |
| 04/24/2013 | CN103059019A Imidazole [4,5-c] pyridine-7-methanamide derivative as well as preparation method and medical application thereof |
| 04/24/2013 | CN103059018A Praziquantel preparation process |
| 04/24/2013 | CN102603742B Extraction method for bufothionine |
| 04/24/2013 | CN102183589B Method for detecting contents of dolasetron isomer and salt thereof |
| 04/24/2013 | CN102015710B Azatricyclic antibiotic compounds |
| 04/24/2013 | CN101914375B Molecular fluorescent switch for detecting intracellular zinc ions and application thereof |
| 04/24/2013 | CN101605793B Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 04/24/2013 | CN101550085B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 04/24/2013 | CN101448397B Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 04/23/2013 | US8426588 Phenylalanine derivatives |
| 04/23/2013 | US8426585 Compounds comprising a spiro-ring |
| 04/23/2013 | US8426441 Inhibitors of bruton's tyrosine kinase |
| 04/23/2013 | US8426437 Pyrroloquinoline derivatives and their use as protein kinases inhibitors |
| 04/23/2013 | US8426425 Aminopyrimidines useful as inhibitors of protein kinases |
| 04/23/2013 | US8426417 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| 04/23/2013 | CA2610042C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/23/2013 | CA2529257C Methods and compositions for treating amyloid-related diseases |
| 04/18/2013 | WO2013056183A1 Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions contianing them |
| 04/18/2013 | WO2013056060A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/18/2013 | WO2013056015A1 Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors |
| 04/18/2013 | WO2013056003A2 Catechol diethers as potent anti-hiv agents |
| 04/18/2013 | WO2013055984A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/18/2013 | WO2013055897A1 8 - carbamoyl - 2 - (2,3- di substituted pyrid - 6 - yl) -1,2,3,4 -tetrahydroisoquinoline derivatives as apoptosis - inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/18/2013 | WO2013055584A1 Solid forms of nematocidal sulfonamides |
| 04/18/2013 | WO2013054291A1 Novel oxazine derivatives and their use in the treatment of disease |
| 04/18/2013 | WO2013054185A1 Pyrimidine and pyridine derivatives useful in therapy |
| 04/18/2013 | WO2013053983A1 Protein kinase inhibitors |
| 04/18/2013 | WO2013053281A1 Asymmetric synthesis method, related raw material and preparation method of (s,s)-2,8-diazabicyclo[4,3,0]nonane |
| 04/18/2013 | WO2013053273A1 Imidazo quinoline derivative and medicinal salt thereof, preparation method thereof and use in medicine thereof |
| 04/18/2013 | WO2013053045A1 Heterocyclic molecules as apoptosis inducers |
| 04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |
| 04/18/2013 | US20130096305 Deuterated hiv attachment inhibitors |
| 04/18/2013 | US20130096155 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent |
| 04/18/2013 | US20130096144 Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors |
| 04/18/2013 | US20130096132 Azaadamantane derivatives and methods of use |